research use only

Sesame Oil

Cat.No.E2918

Sesame oil is a supplement that has anti-inflammatory and antioxidant properties, which make it effective for reducing atherosclerosis and the risk of cardiovascular disease.
Sesame Oil Chemical Structure
Jump to

Quality Control

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight Formula Storage (From the date of receipt) 2 years -20°C liquid
CAS No. 8008-74-0 --

Read more about storage stability stock solution CAS number

Mechanism of Action

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-07-02)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT07665398 ACTIVE_NOT_RECRUITING
Bruxism; Bruxism, Sleep; Bruxism, Sleep-Related
Necmettin Erbakan University
2024-09-02
NCT06592144 ACTIVE_NOT_RECRUITING
Weaning Failure; Muscle Weakness; Mechanical Ventilation Complication; ICU Acquired Weakness; Mobility Limitation
Leticia Maria Defendi Barboza Marson
2024-09-09 PHASE4
NCT07346677 NOT_YET_RECRUITING
Cancer; Chemotherapy
University of Basrah
2026-05-11 PHASE2
NCT07274371 ACTIVE_NOT_RECRUITING
Sleep Disturbances in Perimenopause
Saipriya Gowrishankar
2025-11-06
NCT03877991 UNKNOWN
Pain
Hadassah Medical Organization
2024-02-19 EARLY_PHASE1
NCT06375850 UNKNOWN
Phlebitis
Hospital Universitario Marqués de Valdecilla
2022-06-05

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.